参考文献/References:
[1] World Health Organization. Report of the World Health Organization Expert Committee on Disability Prevention and Rehabilitation:rehabilitation of patients with cardiovascular disease[R]. Geneva:WHO,1964.
[2] Thomas RJ,Beatty AL,Beckie TM,et al. Home-based cardiac rehabilitation:a scientific statement from the American Association of Cardiovascular and Pulmonary Rehabilitation,the American Heart Association,and the American College of Cardiology[J]. Circulation,2019,140(1):e69-e89.
[3] 吴英恺. 重视心血管病的康复治疗研究工作[J].中华心血管病杂志,1981,9(1):1.
[4] 中华医学会心血管病学分会,中国康复医学会心血管病专业委员会,中国老年学学会心脑血管病专业委员会. 冠心病康复与二级预防中国专家共识[J]. 中华心血管病杂志,2013,41(4):267-275.
[5] 丁荣晶,雷莎.中国心脏康复发展历程,现状及思考[J].实用心脑肺血管病杂志,2021,29(9):1-5.
[6] 袁丽霞,丁荣晶. 中国心脏康复与二级预防指南解读[J]. 中国循环杂志,2019,34(S1):86-90.
[7] 中华医学会物理医学与康复学分会,四川大学华西医院. 中国冠心病康复循证实践指南（2024版）第一部分[J]. 中华物理医学与康复杂志,2024,46(6):481-491.
[8] Visserden FLJ,Mach F,Smulders YM,et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice:Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)[J]. Rev Esp Cardiol (Engl Ed),2022,75(5):429.
[9] 高丽梅,李梅,李美玲,等. 基于数字化医院的心脏康复综合干预对PCI术后患者的临床效果[J]. 心血管康复医学杂志,2023,32(1):13-19.
[10] 余慧琳. 心脏康复运动对冠心病合并糖尿病患者PCI术后心肺功能、运动功能和生活质量的影响[J]. 心血管康复医学杂志,2023,32(5):456-459.
[11]Saeidi M,Mostafavi S,Heidari H,et al. Effects of a comprehensive cardiac rehabilitation program on quality of life in patients with coronary artery disease[J]. ARYA Atheroscler,2013,9(3):179-185.
[12] 程会兰,谢丽娜,丰金香,等. 心肺运动试验指导下的心脏康复对冠心病PCI术后患者运动耐量及生活质量的临床研究[J]. 中国康复,2019,34(12):639-642.
[13] Ma J,Zhang JW,Li H,et al. Safety and effectiveness of a Tai Chi-based cardiac rehabilitation programme for chronic coronary syndrom patients:study protocol for a randomised controlled trial[J]. BMJ Open,2020,10(7):e036061.
[14] Dibben GO,Faulkner J,Oldridge N,et al. Exercise-based cardiac rehabilitation for coronary heart disease:a meta-analysis[J]. Eur Heart J,2023,44(6):452-469.
[15] Patti A,Merlo L,Ambrosetti M,et al. Exercise-based cardiac rehabilitation programs in heart failure patients[J]. Heart Fail Clin,2021,17(2):263-271.
[16] 曾德菲,郑婉,魏俊萍,等.运动康复训练对老年冠心病慢性心力衰竭患者心功能的影响[J].中国老年学杂志,2023,43(7):1543-1546.
[17] Austin J,Williams WR,Ross L,et al. Five-year follow-up findings from a randomized controlled trial of cardiac rehabilitation for heart failure[J]. Eur J Cardiovasc Prev Rehabil,2008,15(2):162-167.
[18] O’Connor CM,Whellan DJ,Lee KL,et al. Efficacy and safety of exercise training in patients with chronic heart failure:HF-ACTION randomized controlled trial[J]. JAMA,2009,301(14):1439-1450.
[19] Davies EJ,Moxham T,Rees K,et al. Exercise training for systolic heart failure:cochrane systematic review and meta-analysis[J]. Eur J Heart Fail,2010,12(7):706-715.
[20] Fukuta H,Goto T,Wakami K,et al. Effects of exercise training on cardiac function,exercise capacity,and quality of life in heart failure with preserved ejection fraction:a meta-analysis of randomized controlled trials[J]. Heart Fail Rev,2019,24(4):535-547.
[21]Molloy C, Long L,Mordi IR,et al. Exercise-based cardiac rehabilitation for adults with heart failure[J]. Cochrane Database Syst Rev,2024,3(3):CD003331.
[22] Taylor RS,Walker S,Ciani O,et al. Exercise-based cardiac rehabilitation for chronic heart failure:the EXTRAMATCH Ⅱ individual participant data meta-analysis[J]. Health Technol Assess,2019,23(25):1-98.
[23] Lourens EC,Baker RA,Krieg BM. Quality of life following cardiac rehabilitation in cardiac surgery patients[J]. J Cardiothorac Surg,2022,17(1):137.
[24] Marcassa C,Giordano A,Giannuzzi P. Five-year hospitalisations and survival in patients admitted to inpatient cardiac rehabilitation after cardiac surgery[J]. Eur J Prev Cardiol,2016,23(15):1609-1617.
[25] Sperlongano S,Renon F,Bigazzi MC,et al. Transcatheter aortic valve implantation:the new challenges of cardiac rehabilitation[J]. J Clin Med,2021,10(4):810.
[26] Rogers P,Al-Aidrous S,Banya W,et al. Cardiac rehabilitation to improve health-related quality of life following trans-catheter aortic valve implantation:a randomised controlled feasibility study:RECOVER-TAVI Pilot,ORCA 4,For the Optimal Restoration of Cardiac Activity Group[J]. Pilot Feasibility Stud,2018,4:185.
[27] Ribeiro GS,Melo RD,Deresz LF,et al. Cardiac rehabilitation programme after transcatheter aortic valve implantation versus surgical aortic valve replacement:systematic review and meta-analysis[J]. Eur J Prev Cardiol ,2017,24(7):688-697.
[28] Kachur S,Lavie CJ,de Schutter A,et al. Obesity and cardiovascular diseases[J]. Minerva Med,2017,108(3):212-228.
[29] Heinl RE,Dhindsa DS,Mahlof EN,et al. Comprehensive cardiovascular risk reduction and cardiac rehabilitation in diabetes and the metabolic syndrome[J]. Can J Cardiol,2016,32(10 suppl 2 ):S349-S357.
[30] Mont L,Tamborero D,Elosua R,et al. Physical activity,height,and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals[J]. Europace,2008,10(1):15-20.
[31] Qureshi WT,Alirhayim Z,Blaha MJ,et al. Cardiorespiratory fitness and risk of incident atrial fibrillation:results from the Henry Ford exercise testing (FIT) project[J]. Circulation,2015,131(21):1827-1834.
[32] Mozaffarian D,Furberg CD,Psaty BM,et al. Physical activity and incidence of atrial fibrillation in older adults:the cardiovascular health study[J]. Circulation,2008,118(8):800-807.
[33] Santos-Lozano A,Sanchis-Gomar F,Barrero-Santalla S,et al. Exercise as an adjuvant therapy against chronic atrial fibrillation[J]. Int J Cardiol,2016,207:180-184.
[34] Thelle DS,Selmer R,Gjesdal K,et al. Resting heart rate and physical activity as risk factors for lone atrial fibrillation:a prospective study of 309,540 men and women[J]. Heart,2013,99(23):1755-1760.
[35] Kirchhof P,Benussi S,Kotecha D,et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS[J]. Eur Heart J,2016,37(38):2893-2962.
[36] 中国康复医学会心血管病预防与康复专业委员会,胡大一,陈桂英,等. 心房颤动患者心脏康复中国专家共识[J]. 中华内科杂志,2021,60(2):108-118.
[37] 国家心血管病中心肺动脉高压专科联盟,国家心血管病专家委员会右心与肺血管病专业委员会,中国医学科学院阜外医院. 中国肺动脉高压诊治临床路径[J]. 中国循环杂志,2023,38(7):691-703.
[38] Becker-Grünig T,Klose H,Ehlken N,et al. Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease[J]. Int J Cardiol,2013,168(1):375-381.
[39] Kabitz HJ,Bremer HC,Schwoerer A,et al. The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension[J]. Lung,2014,192(2):321-328.
[40] Fukui S,Ogo T,Takaki H,et al. Efficacy of cardiac rehabilitation after balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension[J]. Heart,2016,102(17):1403-1409.
[41] Grünig E,Ehlken N,Ghofrani A,et al. Effect of exercise and respiratory training on clinical progression and survival in patients with severe chronic pulmonary hypertension[J]. Respiration,2011,81(5):394-401.
[42] Ehlken N,Lichtblau M,Klose H,et al. Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension:a prospective,randomized,controlled trial[J]. Eur Heart J,2016,37(1):35-44.
[43] 中国医师协会心血管内科医师分会,中国医院协会心脏康复管理专业委员会. 成人肺高血压患者运动康复中国专家共识[J]. 中国介入心脏病学杂志,2021,29(8):421-432.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(6):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(6):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(6):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(6):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(6):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(6):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(6):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(6):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[11]詹宇亮 朱虹岷 刘员员 杨 鹏 黄 笑 刘松涛 邹鹏涛 陈艳梅 刘 强 谢国波 蔡新勇.基于虚拟现实的心脏康复在冠心病中的作用：基于随机对照试验的meta分析[J].心血管病学进展,2025,(12):1123.[doi:10.16806/j.cnki.issn.1004-3934.2025.10.014]
ZHAN Yuliang,ZHU Hongmin,LIU Yuanyuan,et al.The Impact of the VR-Based Ccardiac Rehabilitation on Patients with Coronary Heart Disease: A Meta-Analysis of Randomized Controlled Trials[J].Advances in Cardiovascular Diseases,2025,(6):1123.[doi:10.16806/j.cnki.issn.1004-3934.2025.10.014]